Cash flow Lumosa Therapeutics Co., Ltd.

Stocks

6535

TW0006535008

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 11/06/2026			5-day change	1st Jan Change
106.50 ^TWD	-1.39%		-9.75%	-45.24%

11/05	Lumosa Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
23/02	Lumosa Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

e669d7b974ffe61bb4ab874.Nq-9Pd4ZVaLmI5ZVE-zm7OyzCCd7k8LzZe2N3VfIVfI.BPf8Vo1RHdeKd8QBJ4qRlI3UMXQt8PeAF5iguROxJ5Bgwt5o71E_-JUX8Q

Published financial data: LUMOSA THERAPEUTICS CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.74Cr	2.66Cr	5.69Cr	3.92Cr	3.58Cr
Total Revenues	1.74Cr	2.66Cr	5.69Cr	3.92Cr	3.58Cr
Cost of Goods Sold, Total	74.73L	1.21Cr	1.54Cr	2.14Cr	1.4Cr
Gross Profit	98.89L	1.46Cr	4.15Cr	1.77Cr	2.19Cr
Selling General & Admin Expenses, Total	3.41Cr	4Cr	4.78Cr	5.18Cr	5.1Cr
Provision for Bad Debts	-	-	2L	2L	-14T
R&D Expenses	41Cr	28Cr	37Cr	32Cr	30Cr
Other Operating Expenses, Total	44Cr	32Cr	42Cr	37Cr	36Cr
Operating Income	-43Cr	-31Cr	-38Cr	-36Cr	-33Cr
Interest Expense, Total	-3L	-1L	-47T	-2L	-2L
Interest And Investment Income	34.57L	58.4L	1.85Cr	1.34Cr	2.02Cr
Net Interest Expenses	31.97L	56.91L	1.84Cr	1.32Cr	2Cr
Currency Exchange Gains (Loss)	-37.25L	1.1Cr	-42.13L	68.66L	3L
Other Non Operating Income (Expenses)	16.66L	21.07L	27.6L	24.13L	69.14L
EBT, Excl. Unusual Items	-43Cr	-29Cr	-36Cr	-33Cr	-31Cr
Impairment of Goodwill	-7.85Cr	-	-	-	-
Gain (Loss) On Sale Of Investments	63Cr	-22Cr	12Cr	-10Cr	-4.03Cr
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-2.4Cr	-	-1.04Cr	-	-
Other Unusual Items	-	48T	-	-	-
EBT, Incl. Unusual Items	9.59Cr	-50Cr	-25Cr	-44Cr	-35Cr
Income Tax Expense	-	36T	2L	-	-
Earnings From Continuing Operations	9.59Cr	-50Cr	-25Cr	-44Cr	-35Cr
Net Income to Company	9.59Cr	-50Cr	-25Cr	-44Cr	-35Cr
Minority Interest	-	98.2L	1.23Cr	1.21Cr	60.78L
Net Income - (IS)	9.59Cr	-49Cr	-24Cr	-42Cr	-34Cr
Net Income to Common Incl Extra Items	9.59Cr	-49Cr	-24Cr	-42Cr	-34Cr
Net Income to Common Excl. Extra Items	9.59Cr	-49Cr	-24Cr	-42Cr	-34Cr
Per Share Items
Net EPS - Basic	0.64	-3.05	-1.47	-2.6	-2.05
Basic EPS - Continuing Operations	0.64	-3.05	-1.47	-2.6	-2.05
Basic Weighted Average Shares Outstanding	15Cr	16Cr	16Cr	16Cr	17Cr
Net EPS - Diluted	0.64	-3.05	-1.47	-2.6	-2.05
Diluted EPS - Continuing Operations	0.64	-3.05	-1.47	-2.6	-2.05
Diluted Weighted Average Shares Outstanding	15Cr	16Cr	16Cr	16Cr	17Cr
Normalized Basic EPS	-1.78	-1.04	-1.3	-1.21	-1.12
Normalized Diluted EPS	-1.78	-1.04	-1.3	-1.21	-1.12
Supplemental Items
EBITDA	-40Cr	-29Cr	-36Cr	-35Cr	-33Cr
EBITA	-40Cr	-29Cr	-36Cr	-36Cr	-33Cr
EBIT	-43Cr	-31Cr	-38Cr	-36Cr	-33Cr
EBITDAR	-40Cr	-29Cr	-35Cr	-35Cr	-33Cr
Effective Tax Rate - (Ratio)	-	-0.01	-0.1	-	-
Normalized Net Income	-27Cr	-17Cr	-21Cr	-20Cr	-19Cr
Interest on Long-Term Debt	3L	1L	47T	2L	2L
Supplemental Operating Expense Items
Selling and Marketing Expenses	97.67L	1.65Cr	2.17Cr	1.73Cr	1.16Cr
General and Administrative Expenses	2.44Cr	2.35Cr	2.61Cr	3.45Cr	3.94Cr
Research And Development Expense From Footnotes	41Cr	28Cr	37Cr	32Cr	30Cr
Net Rental Expense, Total	30.82L	26.87L	34.89L	28.98L	5L
Imputed Operating Lease Interest Expense	5L	4L	2L	4L	98.57T
Imputed Operating Lease Depreciation	26.31L	22.91L	33.37L	24.87L	4L
Stock-Based Comp., Other (Total)	32.22L	50.28L	85.91L	3.8Cr	-48.93L
Total Stock-Based Compensation	32.22L	50.28L	85.91L	3.8Cr	-48.93L

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	84Cr	52Cr	43Cr	24Cr	18Cr
Short Term Investments	59Cr	67Cr	42Cr	111.73Cr	62Cr
Trading Asset Securities, Total	2.19Cr	-	-	-	-
Total Cash And Short Term Investments	145.21Cr	118.45Cr	84Cr	135.28Cr	80Cr
Accounts Receivable, Total	96.92L	1.4Cr	1.2Cr	2.06Cr	1.29Cr
Other Receivables	1.7Cr	1.8Cr	1.81Cr	1.92Cr	1.15Cr
Total Receivables	2.67Cr	3.2Cr	3.01Cr	3.98Cr	2.44Cr
Inventory	8.24Cr	11Cr	10Cr	9.78Cr	9.88Cr
Prepaid Expenses	5.92Cr	6.09Cr	6.57Cr	4.66Cr	4.46Cr
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	1L	-	20T	20T	3T
Total Current Assets	162.05Cr	138.61Cr	104.4Cr	153.7Cr	97Cr
Gross Property Plant And Equipment	4.09Cr	3.64Cr	5.73Cr	5.36Cr	5.18Cr
Accumulated Depreciation	-2.79Cr	-2.88Cr	-2.98Cr	-3.39Cr	-3.74Cr
Net Property Plant And Equipment	1.3Cr	76.64L	2.75Cr	1.97Cr	1.44Cr
Long-term Investments	67Cr	46Cr	58Cr	58Cr	67Cr
Goodwill	0	0	0	0	0
Other Intangibles, Total	4.36Cr	2.69Cr	6L	5L	4L
Other Long-Term Assets, Total	3L	3L	3L	3L	3L
Total Assets	234.87Cr	188.57Cr	165.63Cr	213.3Cr	165.02Cr
Liabilities
Accounts Payable, Total	1.45Cr	10L	1.53Cr	14.23L	13.12L
Accrued Expenses, Total	4.33Cr	4.71Cr	3.48Cr	3.67Cr	3.93Cr
Current Portion of Leases	54.04L	43.3L	44.93L	41.96L	69.22L
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	46.8L	68.82L	30.36L	30.36L	27.98L
Other Current Liabilities	16Cr	16Cr	16Cr	16Cr	8.07Cr
Total Current Liabilities	22Cr	22Cr	22Cr	20Cr	13Cr
Long-Term Leases	60.82L	4L	81.17L	42.81L	-
Total Liabilities	23Cr	22Cr	23Cr	21Cr	13Cr
Common Stock, Total	163.16Cr	163.1Cr	164.97Cr	168.9Cr	168.82Cr
Additional Paid In Capital	127.14Cr	126.84Cr	136.26Cr	222.32Cr	27Cr
Retained Earnings	-76Cr	-125.61Cr	-149.41Cr	-191.89Cr	-34Cr
Treasury Stock	-	-	-	-	-5.68Cr
Comprehensive Income and Other	-2.3Cr	-1.35Cr	-12Cr	-8.16Cr	-4.72Cr
Total Common Equity	211.86Cr	162.98Cr	140.07Cr	191.17Cr	150.94Cr
Minority Interest	-	4.02Cr	2.79Cr	1.58Cr	97.57L
Total Equity	211.86Cr	167Cr	142.86Cr	192.75Cr	151.92Cr
Total Liabilities And Equity	234.87Cr	188.57Cr	165.63Cr	213.3Cr	165.02Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	16Cr	16Cr	16Cr	17Cr	17Cr
ECS Total Common Shares Outstanding	16Cr	16Cr	16Cr	17Cr	17Cr
Book Value / Share	12.99	9.99	8.49	11.32	9.01
Tangible Book Value	207.5Cr	160.29Cr	140.01Cr	191.12Cr	150.91Cr
Tangible Book Value Per Share	12.72	9.83	8.49	11.32	9.01
Total Debt	1.15Cr	46.9L	1.26Cr	84.77L	69.22L
Net Debt	-144.06Cr	-117.98Cr	-83Cr	-134.43Cr	-79Cr
Debt Equivalent Oper. Leases	2.47Cr	2.15Cr	2.79Cr	2.32Cr	37.76L
Minority Interest, Total (Incl. Fin. Div)	-	4.02Cr	2.79Cr	1.58Cr	97.57L
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	3.07Cr	1.51Cr	1.51Cr	1.24Cr	1.02Cr
Inventories - Work In Process, Total	5.12Cr	8.91Cr	8.54Cr	8.52Cr	8.62Cr
Inventories - Finished Goods, Total	4L	44.2L	34.67L	9L	31.21L
Machinery, Total	2.95Cr	3.18Cr	4.15Cr	4.2Cr	4.18Cr
Full Time Employees	46	47	47	43	39
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	3L	3L

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	9.59Cr	-49Cr	-24Cr	-42Cr	-34Cr
Depreciation & Amortization - CF	64.96L	55.23L	67.04L	82.95L	1.11Cr
Amortization of Goodwill and Intangible Assets - (CF)	2.55Cr	1.64Cr	1.64Cr	-	-
Depreciation & Amortization, Total	3.2Cr	2.19Cr	2.31Cr	82.95L	1.11Cr
Amortization of Deferred Charges, Total - (CF)	81T	2L	3L	1L	1L
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-63Cr	22Cr	-12Cr	10Cr	4.03Cr
Asset Writedown & Restructuring Costs	10Cr	-	1.04Cr	-	-
Stock-Based Compensation (CF)	32.22L	50.28L	85.91L	3.8Cr	-48.93L
Provision and Write-off of Bad Debts	-	-	2L	2L	-14T
Other Operating Activities, Total	1L	-91.78L	-1.98Cr	-1.84Cr	-32.13L
Change In Accounts Receivable	79.26L	-43.06L	18.43L	-88.07L	77.44L
Change In Inventories	-5.06Cr	-2.63Cr	47.69L	61.33L	-10.01L
Change In Accounts Payable	1.45Cr	-1.35Cr	5L	-70T	-1L
Change in Unearned Revenues	-3L	22.02L	-38.46L	-	-2L
Change in Other Net Operating Assets	-3.04Cr	7L	29.12L	9L	-6.98Cr
Cash from Operations	-45Cr	-30Cr	-33Cr	-30Cr	-36Cr
Capital Expenditure	-86T	-22.85L	-1.43Cr	-4L	-7L
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-5L	-	-7L	-	-
Investment in Marketable and Equity Securities, Total	-3.64Cr	-6.69Cr	25Cr	-79Cr	37Cr
Other Investing Activities, Total	-	-	80L	40L	40.88L
Cash from Investing	-3.7Cr	-6.92Cr	24Cr	-79Cr	37Cr
Long-Term Debt Repaid, Total	-54.65L	-46.47L	-43.3L	-41.33L	-67.85L
Total Debt Repaid	-54.65L	-46.47L	-43.3L	-41.33L	-67.85L
Issuance of Common Stock	44Cr	8L	3L	90Cr	-
Repurchase of Common Stock	-	-	-	-	-5.68Cr
Other Financing Activities, Total	-	5Cr	98T	-	-
Cash from Financing	43Cr	4.62Cr	-39.45L	89Cr	-6.36Cr
Foreign Exchange Rate Adjustments	-12T	22T	-26T	47T	3T
Net Change in Cash	-5.83Cr	-32Cr	-9.16Cr	-19Cr	-5.39Cr
Supplemental Items
Cash Interest Paid	3L	1L	47T	2L	2L
Cash Income Tax Paid (Refund)	57T	-6L	6L	4L	-67.19L
Levered Free Cash Flow	-29Cr	-21Cr	-21Cr	-18Cr	-26Cr
Unlevered Free Cash Flow	-29Cr	-21Cr	-21Cr	-18Cr	-26Cr
Change In Net Working Capital	5.88Cr	4.08Cr	-58.7L	26.15L	5.64Cr
Net Debt Issued / Repaid	-54.65L	-46.47L	-43.3L	-41.33L	-67.85L

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-13.01	-9.03	-13.26	-11.78	-11.02
Return on Total Capital	-14.42	-10.05	-15.08	-13.22	-12.04
Return On Equity %	5.18	-26.63	-16.16	-26.03	-20.11
Return on Common Equity	5.18	-26.39	-15.71	-25.65	-19.91
Margin Analysis
Gross Profit Margin %	56.96	54.65	72.88	45.24	61.04
SG&A Margin	196.53	150.22	83.99	132.3	142.35
EBITDA Margin %	-2.33T	-1.08T	-627.12	-901.63	-918.66
EBITA Margin %	-2.33T	-1.09T	-631.42	-912.09	-930.73
EBIT Margin %	-2.48T	-1.15T	-660.23	-912.09	-930.73
Income From Continuing Operations Margin %	552.62	-1.89T	-439.83	-1.12T	-967.37
Net Income Margin %	552.62	-1.86T	-418.23	-1.08T	-950.41
Net Avail. For Common Margin %	552.62	-1.86T	-418.23	-1.08T	-950.41
Normalized Net Income Margin	-1.54T	-636.65	-372.39	-503.32	-517.36
Levered Free Cash Flow Margin	-1.69T	-777.49	-372.63	-459.75	-723.54
Unlevered Free Cash Flow Margin	-1.69T	-777.14	-372.57	-459.45	-723.19
Asset Turnover
Asset Turnover	0.01	0.01	0.03	0.02	0.02
Fixed Assets Turnover	1.07	2.58	3.23	1.66	2.1
Receivables Turnover (Average Receivables)	1.48	2.25	4.38	2.4	2.14
Inventory Turnover (Average Inventory)	0.13	0.13	0.15	0.21	0.14
Short Term Liquidity
Current Ratio	7.23	6.44	4.75	7.64	7.37
Quick Ratio	6.6	5.65	3.98	6.92	6.28
Operating Cash Flow to Current Liabilities	-2.02	-1.4	-1.49	-1.47	-2.75
Days Sales Outstanding (Average Receivables)	247.33	162.28	83.37	152.54	170.82
Days Outstanding Inventory (Average Inventory)	2.79T	2.89T	2.51T	1.72T	2.57T
Average Days Payable Outstanding	45.65	73.67	471.58	34.86	33.37
Cash Conversion Cycle (Average Days)	2.99T	2.97T	2.13T	1.84T	2.71T
Long Term Solvency
Total Debt/Equity	0.54	0.28	0.88	0.44	0.46
Total Debt / Total Capital	0.54	0.28	0.87	0.44	0.45
LT Debt/Equity	0.29	0.02	0.57	0.22	-
Long-Term Debt / Total Capital	0.29	0.02	0.56	0.22	-
Total Liabilities / Total Assets	9.8	11.44	13.75	9.63	7.94
EBIT / Interest Expense	-1.65T	-2.05T	-8T	-1.91T	-1.66T
EBITDA / Interest Expense	-1.53T	-1.91T	-7.5T	-1.87T	-1.6T
(EBITDA - Capex) / Interest Expense	-1.53T	-1.92T	-7.81T	-1.87T	-1.61T
Total Debt / EBITDA	-0.03	-0.02	-0.04	-0.02	-0.02
Net Debt / EBITDA	3.62	4.15	2.36	3.85	2.46
Total Debt / (EBITDA - Capex)	-0.03	-0.02	-0.03	-0.02	-0.02
Net Debt / (EBITDA - Capex)	3.62	4.12	2.27	3.85	2.45
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-19.81	53.45	113.63	-31.21	-8.49
Gross Profit, 1 Yr. Growth %	-24.84	47.24	184.88	-57.3	23.49
EBITDA, 1 Yr. Growth %	29.13	-28.52	23.65	-1.09	-6.76
EBITA, 1 Yr. Growth %	28.07	-28.47	24.13	-0.63	-6.62
EBIT, 1 Yr. Growth %	25.98	-28.9	22.84	-4.96	-6.62
Earnings From Cont. Operations, 1 Yr. Growth %	-129.74	-625.8	-50.38	74.5	-20.65
Net Income, 1 Yr. Growth %	-129.74	-615.56	-51.88	78.45	-19.83
Normalized Net Income, 1 Yr. Growth %	23.63	-36.76	24.96	-7.02	-5.94
Diluted EPS Before Extra, 1 Yr. Growth %	-123.85	-578.89	-51.8	76.87	-21.15
Accounts Receivable, 1 Yr. Growth %	-29.96	44.43	-14.25	71.91	-37.46
Inventory, 1 Yr. Growth %	159.28	31.92	-4.39	-5.9	1.02
Net Property, Plant and Equip., 1 Yr. Growth %	-33.31	-41.06	259.16	-28.5	-26.63
Total Assets, 1 Yr. Growth %	31.63	-19.71	-12.17	28.78	-22.63
Tangible Book Value, 1 Yr. Growth %	47.01	-22.75	-12.65	36.5	-21.04
Common Equity, 1 Yr. Growth %	33.86	-23.07	-14.06	36.48	-21.04
Cash From Operations, 1 Yr. Growth %	250.55	-33.62	9.24	-9.72	21.65
Capital Expenditures, 1 Yr. Growth %	-87.35	2.56T	526.52	-96.86	48.44
Levered Free Cash Flow, 1 Yr. Growth %	-7.32T	-29.33	2.39	-15.12	44.02
Unlevered Free Cash Flow, 1 Yr. Growth %	-7.15T	-29.32	2.42	-15.17	44.04
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-68.23	10.93	81.06	21.23	-20.66
Gross Profit, 2 Yr. CAGR %	-73.74	5.2	104.81	10.29	-27.38
EBITDA, 2 Yr. CAGR %	85.44	-3.92	-5.98	10.59	-3.97
EBITA, 2 Yr. CAGR %	80.88	-4.29	-5.77	11.06	-3.67
EBIT, 2 Yr. CAGR %	69.39	-5.36	-6.55	8.04	-5.79
Earnings From Cont. Operations, 2 Yr. CAGR %	-36.9	25.06	61.53	-6.95	17.67
Net Income, 2 Yr. CAGR %	-36.9	23.84	57.51	-7.33	19.61
Normalized Net Income, 2 Yr. CAGR %	25.52	-11.58	-11.1	7.79	-6.48
Diluted EPS Before Extra, 2 Yr. CAGR %	-44.32	6.88	51.92	-7.67	18.09
Accounts Receivable, 2 Yr. CAGR %	-81.69	0.58	11.29	21.41	3.69
Inventory, 2 Yr. CAGR %	85.28	84.94	12.31	-5.15	-2.5
Net Property, Plant and Equip., 2 Yr. CAGR %	-11.88	-37.31	45.5	60.25	-27.57
Total Assets, 2 Yr. CAGR %	33.17	2.8	-16.02	6.35	-0.18
Tangible Book Value, 2 Yr. CAGR %	56.32	6.56	-17.86	9.2	3.82
Common Equity, 2 Yr. CAGR %	42.33	1.48	-18.69	8.3	3.81
Cash From Operations, 2 Yr. CAGR %	9.2	52.55	-14.84	-0.69	4.8
Capital Expenditures, 2 Yr. CAGR %	-	83.31	1.19T	-55.62	-78.4
Levered Free Cash Flow, 2 Yr. CAGR %	27.71	614.39	-14.94	-6.78	10.56
Unlevered Free Cash Flow, 2 Yr. CAGR %	27.73	606.07	-14.92	-6.79	10.54
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-34.08	-46.3	38.01	31.14	10.38
Gross Profit, 3 Yr. CAGR %	-40.01	-53.35	46.63	21.45	14.53
EBITDA, 3 Yr. CAGR %	47.22	34.96	4.51	-4.38	4.47
EBITA, 3 Yr. CAGR %	44.87	32.77	4.38	-4.09	4.83
EBIT, 3 Yr. CAGR %	46.06	26.83	3.23	-6.02	2.92
Earnings From Cont. Operations, 3 Yr. CAGR %	23.95	27.93	-8.1	65.74	-11.76
Net Income, 3 Yr. CAGR %	23.95	27.1	-9.63	64.2	-11.7
Normalized Net Income, 3 Yr. CAGR %	50.61	-0.12	-0.77	-9.76	3.01
Diluted EPS Before Extra, 3 Yr. CAGR %	7.69	14.08	-18.04	59.82	-12.4
Accounts Receivable, 3 Yr. CAGR %	-34.22	-63.55	-4.63	28.64	-2.68
Inventory, 3 Yr. CAGR %	901.56	65.45	48.43	5.88	-3.13
Net Property, Plant and Equip., 3 Yr. CAGR %	-39.48	-22.94	12.18	14.82	23.51
Total Assets, 3 Yr. CAGR %	18.98	12.5	-2.45	-3.16	-4.35
Tangible Book Value, 3 Yr. CAGR %	28.03	23.59	-0.27	-2.7	-1.99
Common Equity, 3 Yr. CAGR %	18.5	15.94	-3.99	-3.37	-2.52
Cash From Operations, 3 Yr. CAGR %	76.8	-7.49	36.48	-13.17	6.26
Capital Expenditures, 3 Yr. CAGR %	-74.36	-	176.12	73.61	-33.63
Levered Free Cash Flow, 3 Yr. CAGR %	44.69	4.85	273.86	-15	7.77
Unlevered Free Cash Flow, 3 Yr. CAGR %	44.67	4.86	270.99	-15	7.77
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.85	-5.45	-1.25	-25.62	10.6
Gross Profit, 5 Yr. CAGR %	-0.27	-10.28	-1.97	-34.18	10.7
EBITDA, 5 Yr. CAGR %	9.1	13.55	23.04	24.62	1.03
EBITA, 5 Yr. CAGR %	8.64	12.69	21.97	23.62	1.08
EBIT, 5 Yr. CAGR %	9.98	9.36	22.17	18.95	-0.48
Earnings From Cont. Operations, 5 Yr. CAGR %	-16.02	18.84	37.8	12.64	1.45
Net Income, 5 Yr. CAGR %	-16.02	18.37	36.42	12.01	1.09
Normalized Net Income, 5 Yr. CAGR %	13.33	4.98	21.97	2.97	-3.1
Diluted EPS Before Extra, 5 Yr. CAGR %	-24.76	6.37	23.58	4.82	-5.15
Accounts Receivable, 5 Yr. CAGR %	-	87.75	-18.82	-41.02	-1.39
Inventory, 5 Yr. CAGR %	-	-	317.42	32.44	25.46
Net Property, Plant and Equip., 5 Yr. CAGR %	-7.96	-12.08	-14.05	3.28	-5.83
Total Assets, 5 Yr. CAGR %	20.66	18.45	3.5	10	-1.55
Tangible Book Value, 5 Yr. CAGR %	19.96	18.32	7.21	17.62	1.35
Common Equity, 5 Yr. CAGR %	19.42	18.7	1.93	12.82	-0.94
Cash From Operations, 5 Yr. CAGR %	25.83	34.44	32	-4.83	22.8
Capital Expenditures, 5 Yr. CAGR %	-52.1	1.85	22.92	-	-0.36
Levered Free Cash Flow, 5 Yr. CAGR %	28.07	107.12	17	0.03	129.65
Unlevered Free Cash Flow, 5 Yr. CAGR %	28.06	107.1	16.99	0.04	128.57